IGHE and chronic asthma: In this study, our findings demonstrate the effectiveness of rosuvastatin in reducing the presence of eosinophils and neutrophils, as well as the production of Th2 cytokines and OVA-specific IgE in a mouse model of chronic asthma caused by OVA, which is a characteristic of Th2-driven inflammation.